Description
Crystagen 20mg — Immune-cell biology and peptide bioregulation.
Crystagen 20mg is a short peptide bioregulator studied in experimental immune-cell and ageing research. This product listing covers the 20 mg vial.
What the Research Shows
Published work has investigated short peptides including Crystagen in relation to spleen biology and age-associated changes in immune cells. This is preclinical research context. It should not be interpreted as a claim that this vial improves immunity or prevents disease. See the Crystagen and immune-cell research for the original context.
Crystagen 20mg Product Details
- Product: Crystagen 20mg
- Labelled amount: 20 mg per vial
- Research context: Immune-cell biology and peptide bioregulation
- Product code: CRY20
Batch-specific identity and analytical specifications should be checked against the matching supplier documentation. Published research describes the authors’ materials and methods; it is not a certificate of analysis for this product.
Related Research Resources
Explore the Purpose Labs research library for further background. Related catalogue entries include Thymosin Alpha-1 10mg and KPV 10mg. These are separate compounds with their own research profiles.
For research use only. Not for human consumption.




